Semaglutide is FDA-approved for chronic weight management and type 2 diabetes
Semaglutide can initially increase loose stools in some patients, and this effect may be more noticeable if you already experience bile acid diarrhea
Hadidchi carefully evaluates each patients medical history, metabolic health, and personal preferences before recommending any prescription therapy, including GLP-1 medications, as part of a comprehensive treatment plan
Data Extraction Extracted variables included study design, peptide agent and formulation, dosing regimen and route of administration when reported, musculoskeletal indication, comparator group, outcome measures, efficacy findings, and adverse events
2020;10(12):e01851
TrimRx comes out ahead once you factor in Mochi's membership fee and mandatory video visit